Carpathian Research Group

Executive Summary

Carpathian Research Group (CRG) is a specialized clinical research organization (CRO) headquartered in Bucharest, Romania, founded in 2019. The company focuses on supporting clinical trials across Eastern Europe, the Balkans, and Central Asia, leveraging deep regional expertise to offer services including regulatory submissions, study feasibility, document translation, and project management. By providing a comprehensive suite of in-house capabilities and a well-established local network, CRG enables sponsors to efficiently navigate the regulatory and logistical complexities of these emerging clinical trial destinations. The firm serves a growing demand for decentralized and cost-effective trial solutions, positioning itself as a key partner for pharmaceutical and biotech companies seeking to diversify their clinical operations beyond traditional hubs. CRG's business model is built on project-based fees and long-term service agreements, with a focus on high-quality data and accelerated patient recruitment. The company is well-positioned to benefit from increasing pharmaceutical R&D investment in Europe and the trend toward globalizing clinical trials. While still privately held and relatively early-stage, CRG has the potential to capture significant market share in underpenetrated regions by expanding its service offerings and forging strategic partnerships. Future growth will depend on its ability to scale operations, attract top-tier sponsors, and potentially expand into adjacent therapeutic areas. The company's regional specialization serves as a strong competitive moat in a fragmented CRO landscape.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Top 20 Pharma40% success
• Q2 2027Expansion into Western European Markets30% success
• Q4 2026Launch of AI-Powered Trial Management Platform50% success